Clonidine decreases kynurenic acid production in rat brain cortex in vitro – a novel antihypertensive mechanism of action?

Journal Title: Journal of Pre-Clinical and Clinical Research - Year 2016, Vol 10, Issue 1

Abstract

[b]Introduction and objective. [/b]Clonidine, an antihypertensive agent, is known to activate presynaptic α2-adrenoreceptors and imidazoline receptors in the central nervous system. Clonidine may also have influence on glutamatergic neurotransmission. Kynurenic acid (KYNA) is an endogenous antagonist of excitatory amino acid receptors. Cerebral KYNA synthesis from its bioprecursor L-kynurenine is regulated by aminotransferases localized preferentially within astrocytes. KYNA was shown to display potent neuroprotective properties. Moreover, it was reported that KYNA could reduce blood pressure levels in animal model of hypertension. The aim of the study was to discover whether the central antihypertensive agent clonidine has an influence on kynurenic acid (KYNA) production in rat brain cortex in vitro. [b]Materials and method.[/b] Cortical slices and brain cortical homogenates were incubated for 2 hours in the presence of KYNA precursor – L-kynurenine and clonidine. KYNA was separated chromatographically and detected fluorometrically. [b]Results.[/b] Clonidine at the concentration of 0.001 mM – 0.1 mM did not affect KYNA production in rat brain cortex [i]in vitro[/i]. It decreased KYNA production in rat brain cortical slices at concentrations 0.5–5 mM. Clonidine at all tested concentrations influenced neither KAT I nor KAT II activity. [b]Conclusion. [/b]The study revealed that clonidine decreases KYNA production in rat brain cortex in vitro. The obtained results suggest that augmentation of glutamatergic transmission may play an important role in the antihypertensive action of clonidine.

Authors and Affiliations

Izabela Zakrocka, Waldemar Turski, Tomasz Kocki

Keywords

Related Articles

Influence of coffee drinking on epilepsy control

Caffeine is a global stimulant the increased intake of which leads to a lowering of the seizure threshold, which may result in reduced control of epilepsy. Two cases are reported: a male with well-controlled epilepsy, an...

Levels of interleukin-2 in patients with colon cancer and diabetes type 2

[b]Introduction and objectives.[/b] The risk of development colon cancer (CC) is increased significantly among patients with the type 2 diabetes (T2DM). A mechanism responsible for the higher prevalence of CC among diabe...

Foot metastasis as a first clinical manifestation of rectal carcinoma

The incidence of colorectal carcinoma in the European population is high. The present paper describes the case of a farmer whose first symptom of rectal carcinoma was a metastatic tumour to the foot bones. Histopatholog...

Neuroprotective effects of some newer and potential antiepileptic drugs

Experimental models of epilepsy or [i]status epilepticus [/i](SE) provide evidence that seizures result in diffuse brain damage. Other neurological conditions are also associated with neurodegeneration, for example, stro...

Benefits of alpha-ketoglutarate versus succinate on rat muscle dysfunction as a result of exposure to a uremic environment[sub][/sub]

Muscle weakness is a prominent feature of end-state renal failure. While the cause of this strongly disabling muscle condition is at present unknown, there are suggestions that metabolic factors may play a role in this t...

Download PDF file
  • EP ID EP79300
  • DOI 10.5604/18982395.1208190
  • Views 107
  • Downloads 0

How To Cite

Izabela Zakrocka, Waldemar Turski, Tomasz Kocki (2016). Clonidine decreases kynurenic acid production in rat brain cortex in vitro – a novel antihypertensive mechanism of action?. Journal of Pre-Clinical and Clinical Research, 10(1), 57-59. https://www.europub.co.uk/articles/-A-79300